Planning a Bayesian early-phase phase I/II study for human vaccines in HER2 carcinomas.
Authors:
Zohar S, Baldi I, Forni G, Merletti F, Masucci G, Gregori D.
Source:
Pharm Stat 2011; 10: 218-26.
Zohar S, Baldi I, Forni G, Merletti F, Masucci G, Gregori D.
Pharm Stat 2011; 10: 218-26.